Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer

(2021) Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer. Journal of Cellular Physiology. pp. 6168-6189. ISSN 0021-9541

Full text not available from this repository.

Abstract

A recently proposed term "immunometabolism" points to the functional intracellular metabolic changes that occur within different immune cells. Recent findings suggest that immune responses can be determined by the metabolic status of immune cells and metabolic reprogramming is an important feature of immune cell activation. Metabolic reprogramming is also well known for cancer cells and has been suggested as a major sign of cancer progression. Metabolic reprogramming of immune cells is also seen in the tumor microenvironment. In the past decade, immunometabolism has progressively become an extraordinarily vibrant and productive area of study in immunology because of its importance for immunotherapy. Understanding the immunometabolic situation of T cells and other immune cells along with the metabolic behavior of cancer cells can help us design new therapeutic approaches against cancers. Here, we have the aim to review the cutting-edge findings on the immunometabolic situation in immune and tumor cells. We discuss new findings on signaling pathways during metabolic reprogramming, its regulation, and the participation of reactive oxygen species in these processes.

Item Type: Article
Keywords: immunometabolism metabolic reprogramming reactive oxygen species T cells tumor cells
Page Range: pp. 6168-6189
Journal or Publication Title: Journal of Cellular Physiology
Journal Index: ISI
Volume: 236
Number: 9
Identification Number: https://doi.org/10.1002/jcp.30303
ISSN: 0021-9541
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/14052

Actions (login required)

View Item View Item